Boucher R C
Clin Chest Med. 1981 Sep;2(3):377-92.
The paper has focused on interactions of inhaled agents with airway surfaces. The respiratory mucosa is directly exposed to relatively high concentrations of inhaled substances and pollutant-related increases in incidence of infections and bronchospasm may reflect dysfunction of this barrier. Although the description of the mechanisms of toxicity to this surface are preliminary, it is clear that the challenge for the future will be to identify such toxic mechanisms. Too many environmental compounds are of concern and too many protocols are required to thoroughly study the toxicology and human health effects of individual compounds. An understanding of mechanisms is needed to categorize these compounds toxicologically to predict interactions between compounds in their effects on airways, and perhaps, to deal with the genetic variability of response demonstrated by individual subjects. A challenging need in future research will be to utilize observations on mechanisms made in animal models and in vitro to design well-focused experiments with human subjects.
该论文聚焦于吸入性制剂与气道表面的相互作用。呼吸道黏膜直接暴露于相对高浓度的吸入物质中,与污染物相关的感染和支气管痉挛发病率增加可能反映了这一屏障的功能障碍。尽管对该表面毒性机制的描述尚属初步,但显然未来的挑战将是识别此类毒性机制。令人担忧的环境化合物太多,全面研究单个化合物的毒理学和对人类健康的影响需要太多方案。需要了解机制以便对这些化合物进行毒理学分类,以预测化合物之间对气道影响的相互作用,或许还能应对个体受试者表现出的反应遗传变异性。未来研究中一项具有挑战性的需求将是利用在动物模型和体外对机制的观察结果来设计针对人类受试者的重点明确的实验。